메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

BTL Announces Successful Enforcement of Patent Rights R…

PRAGUE, Jan. 22, 2026 -- BTL Group, a global leader in medical technologies, today announced the successful resolution of multiple patent infringement proceedings against Lexter Microelectronic Engineering Systems S.L. ("Lexter"), the manufacturer of the WonderFace device. The settlement follows patent infringement litigation initiated by BTL in multiple jurisdictions to protect its proprietary EMFACE® technology. As a result of the settlement, Lexter has agreed to cease the manufacture, global marketing and distribution, and use of facial treatment technologies a
- 김갑성 기자
- 2026-01-22 16:00
Immfly to Bring Eutelsat's OneWeb LEO High-Speed Connectivity…

[ 메디채널 김갑성 기자 ] Immfly to deliver Eutelsat's OneWeb cutting-edge LEO high-speed connectivity in 2026, with full installations in just 24–30 hours Aircraft to be equipped with Gogo's next-generation electronically steered antenna and Immfly's agnostic server Equilux Aero This solution empowers LCCs/ULCCs to unlock new revenue streams, streamline operations, and offer passengers broadband internet without major CapEx or downtime BARCELONA, Spain, Jan. 22, 2026 -- Immfly, the global technology company redefining the in-flight experience through its integrated ecosystem of entertai
- 김갑성 기자
- 2026-01-22 14:30
2026 Japan Prize Laureates Announced

TOKYO, Jan. 22, 2026 -- The Japan Prize Foundation announced the winners of the 2026 Japan Prize on January 21, 2026. Prof. Cynthia Dwork (USA) has received the Japan Prize in the field of Electronics, Information, and Communication. Prof. Shizuo Akira (Japan) and Prof. Zhijian "James" Chen (USA) have received the Japan Prize in the field of Life Sciences. - Field Eligible for the Award: Electronics, Information, and CommunicationImage of Prof. Cynthia Dwork: https://cdn.kyodonewsprwire.jp/prwfile/release/M000319/202601142440/_prw_PI1fl_4D06A8QY.jpg - Field Eligible f
- 김갑성 기자
- 2026-01-22 14:00
Telangana (India) Sets Global Ambition with Next-Gen Life Sci…

[ 메디채널 김갑성 기자 ] Positioning Telangana among the world's top five life sciences clusters by 2030 Targets USD 25 billion in investments Shifts focus from scale-led manufacturing to innovation-driven, value creation DAVOS, Switzerland, Jan. 22, 2026 -- The Government of Telangana, India today unveiled its Next-Gen Life Sciences Policy 2026–30 at the World Economic Forum 2026 in Davos, signalling the State's intent to play a far more consequential role in shaping the future of global healthcare, advanced therapeutics, and sustainable bio-manufacturing. The policy ar
- 김갑성 기자
- 2026-01-22 09:00
BE BOLD & GLOBAL: BE International Triumphs at Functional Fo…

BANGKOK, Jan. 22, 2026 -- BE International has achieved a spectacular triple victory at the Functional Foods for Wellness Awards 2026 ceremony, held on 20th January 2026 at the Pullman Bangkok King Power in Bangkok, Thailand. The company was honoured with three prestigious accolades for its flagship BElixz series, recognising SHIRUTO, LIVCORE, and I-VXION as category leaders. This achievement underscores BE International's commitment to its 2026 motto, "BE BOLD & GLOBAL", and its enduring mission to go "Beyond Eternity" by delivering world-class wellness solutions.&nbs
- 김갑성 기자
- 2026-01-22 05:00
Shaklee Announces Leadership Change with Appointmen…

MIAMI and TAIPEI, Jan. 21, 2026 -- Shaklee, a global leader in health and wellness, today announced the appointment of Scarlett Su as President of Shaklee Taiwan, effective immediately. Scarlet brings extensive leadership experience in the direct selling and wellness industries, with a strong track record of driving sustainable growth through high-performance team culture, innovative social media strategies, and community-focused marketing initiatives. She has spent over 30 years helping build and scale successful local brands, including more than a decade in senior leadership
- 김갑성 기자
- 2026-01-22 03:47
TraceLink Marks Five Years of Sustained Global Impact Throu…

From pandemic response to long-term community investment, TraceLink's corporate grants have supported 60 nonprofit organizations worldwide SummaryFrom 2020 through 2025, TraceLink's corporate grant program supported 60 nonprofit organizations worldwide, advancing healthcare access, food security, education, humanitarian relief, and community resilience as an extension of its mission to protect patients and strengthen the communities where its employees live and work. BOSTON, Jan. 21, 2026 -- TraceLink today announced the five-year impact of its corporate grant program, h
- 김갑성 기자
- 2026-01-21 23:00
Datasea Pre-Announces Fiscal Year 2026 Second Quarter Re…

Gross Profit Increased 278% Year-over-Year with Significant Improvement in Gross Margin BEIJING, Jan. 21, 2026 -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a Nevada-based technology company specializing in acoustic high-tech solutions and 5G+AI multimodal digitalization, today pre-announced its unaudited financial results for the second quarter of fiscal year 2026, ended December 31, 2025. The financial highlights below are presented on a six-month basis for the period ended December 31, 2025. Fiscal Year 2026 Seco
- 김갑성 기자
- 2026-01-21 22:30
Trisol Medical Announces Positive Results from U.S. Early Fea…

[ 메디채널 김갑성 기자 ] Results demonstrate a favorable safety profile and functional improvements in patients with severe tricuspid regurgitation including patients with reduced right ventricle function YOKNEAM, Israel, Jan. 21, 2026 -- Trisol Medical, a clinical-stage medical device company developing a transcatheter tricuspid valve replacement system, today announced positive results from its FDA-approved U.S. Early Feasibility Study evaluating the Trisol Transcatheter Tricuspid Valve in patients with severe to torrential tricuspid regurgitation. Trisol's
- 김갑성 기자
- 2026-01-21 21:55
DIA Launches ASCENT Platform and LIFT Biotech & Startup Prog…

WASHINGTON, Jan. 21, 2026 -- The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to support early-stage biotechnology drug development innovation, along with its inaugural initiative, the LIFT (Linking Innovation, Funding, and Translation) Series. Together, ASCENT and LIFT create a structured, multi-stage pathway to educate, prepare, and connect emerging biotech and startup companies with investors, regulators, pharma leaders, and development organizations across the full product lifecycle. Built to address persistent
- 김갑성 기자
- 2026-01-21 21:39

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2026-01-31_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 31일 13시 40분